RAMIRO MONTALVO: Open Payments
NPI 1225147135 · BROOKHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 76 payments from 21 companies in 2025. Trend: 2023 $1,899 · 2024 $1,411 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $250 |
| Corcept Therapeutics | 5 | $213 |
| Bayer Healthcare Pharmaceuticals Inc. | 9 | $172 |
| Amgen Inc. | 10 | $150 |
| PFIZER INC. | 7 | $115 |
| ABBVIE INC. | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Lilly USA, LLC | 4 | $62 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Novo Nordisk Inc | 3 | $56 |
Products named: Korlym, Kerendia, BREZTRI, AIRSUPRA, ELIQUIS, EVENITY, MOUNJARO, LEQVIO.
Industry payments across MS — which companies pay providers there.
